AKT1 and glioblastoma: The results of annexin PE/7-AAD revealed that SAA1 knockdown significantly increased GBM cells apoptosis caused by TMZ treatment, and AKT phosphorylation activator SC79 weaken the effects of SAA1 down-regulation (Fig. 4C, D).